Oxford BioMedica plc Company Profile (LON:OXB)

About Oxford BioMedica plc (LON:OXB)

Oxford BioMedica plc logoOxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D segment is engaged in the development of in-vivo and ex-vivo gene and cell therapy products, and the development of lentivirus-related platform technology. The Company provides a platform of technologies and capabilities with which it designs, develops and produces gene and cell-based medicines. The Company's product pipeline of OXB-102, OXB-201, OXB-202 and OXB-302 addresses neurodegenerative and ocular diseases, and a range of cancers. OXB-102 is indicated for Parkinson's disease. OXB-202 is indicated for Ocular (corneal graft rejection). OXB-302 is indicated for cancer disease. Its OXB-201 is indicated for wet age-related macular degeneration.

Industry, Sector and Symbol:
  • Sector:
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:OXB
  • CUSIP: N/A
  • Web: N/A
  • Market Cap: £156.98 million
  • Outstanding Shares: 3,083,993,000
Average Prices:
  • 50 Day Moving Avg: GBX 4.88
  • 200 Day Moving Avg: GBX 4.36
  • 52 Week Range: GBX 2.98 - GBX 6
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £27.78 million
  • Price / Sales: 5.65
  • Book Value: N/A
  • Price / Book: N/A
  • EBIDTA: ($7,640,000.00)
  • Average Volume: 5.12 million shs.

Frequently Asked Questions for Oxford BioMedica plc (LON:OXB)

What is Oxford BioMedica plc's stock symbol?

Oxford BioMedica plc trades on the London Stock Exchange (LON) under the ticker symbol "OXB."

Where is Oxford BioMedica plc's stock going? Where will Oxford BioMedica plc's stock price be in 2017?

2 analysts have issued 1-year target prices for Oxford BioMedica plc's shares. Their predictions range from GBX 3.30 to GBX 8. On average, they expect Oxford BioMedica plc's share price to reach GBX 5.65 in the next twelve months. View Analyst Ratings for Oxford BioMedica plc.

Who are some of Oxford BioMedica plc's key competitors?

Who are Oxford BioMedica plc's key executives?

Oxford BioMedica plc's management team includes the folowing people:

  • John Dawson, Chief Executive Officer, Executive Director

How do I buy Oxford BioMedica plc stock?

Shares of Oxford BioMedica plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford BioMedica plc's stock price today?

One share of Oxford BioMedica plc stock can currently be purchased for approximately GBX 5.09.

MarketBeat Community Rating for Oxford BioMedica plc (LON OXB)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  135
MarketBeat's community ratings are surveys of what our community members think about Oxford BioMedica plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Oxford BioMedica plc (LON:OXB) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 5.65

Analysts' Ratings History for Oxford BioMedica plc (LON:OXB)
DateFirmActionRatingPrice TargetDetails
3/17/2017Jefferies Group LLCReiterated RatingBuyGBX 8View Rating Details
3/16/2017N+1 SingerReiterated RatingHoldGBX 3.30View Rating Details
(Data available from 5/30/2015 forward)


Earnings History for Oxford BioMedica plc (LON:OXB)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for Oxford BioMedica plc (LON:OXB)
Current Year EPS Consensus Estimate: $-0.35 EPS


Dividend History for Oxford BioMedica plc (LON:OXB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Oxford BioMedica plc (LON:OXB)
Insider Trades by Quarter for Oxford BioMedica plc (LON:OXB)
Insider Trades by Quarter for Oxford BioMedica plc (LON:OXB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2017Lorenzo TallarigoInsiderBuy53,260GBX 5£2,663
4/24/2017Lorenzo TallarigoInsiderBuy54,090GBX 5£2,704.50
3/23/2017Lorenzo TallarigoInsiderBuy49,468GBX 5£2,473.40
2/24/2017Lorenzo TallarigoInsiderBuy67,165GBX 4£2,686.60
12/15/2016Lorenzo TallarigoInsiderBuy65,993GBX 4£2,639.72
11/25/2016Lorenzo TallarigoInsiderBuy75,417GBX 4£3,016.68
10/25/2016Lorenzo TallarigoInsiderBuy77,864GBX 3£2,335.92
9/26/2016Lorenzo TallarigoInsiderBuy79,988GBX 3£2,399.64
8/25/2016Tallarigo ,LorenzoInsiderBuy62,257GBX 4£2,490.28
7/25/2016Tallarigo ,LorenzoInsiderBuy63,351GBX 4£2,534.04
6/24/2016Tallarigo ,LorenzoInsiderBuy62,847GBX 4£2,513.88
5/13/2016Diggle ,MartinInsiderBuy42,072GBX 5£2,103.60
5/12/2016Diggle ,MartinInsiderBuy45,428GBX 5£2,271.40
5/5/2016Diggle ,MartinInsiderBuy12,500GBX 6£750
5/4/2016Diggle ,MartinInsiderBuy44,689GBX 6£2,681.34
5/3/2016Diggle ,MartinInsiderBuy317,382GBX 6£19,042.92
4/29/2016Nolan,PeterInsiderBuy359,925GBX 6£21,595.50
4/22/2016Tallarigo ,LorenzoInsiderBuy41,083GBX 6£2,464.98
3/24/2016Tallarigo ,LorenzoInsiderBuy41,550GBX 6£2,493
2/26/2016Diggle ,MartinInsiderBuy29,345GBX 7£2,054.15
2/25/2016Tallarigo ,LorenzoInsiderBuy36,370GBX 7£2,545.90
2/24/2016Diggle ,MartinInsiderBuy46,693GBX 6£2,801.58
7/1/2015Diggle ,MartinInsiderBuy284,439GBX 0.09£256
6/30/2015Diggle ,MartinInsiderBuy775,000GBX 0.09£697.50
6/19/2015Diggle ,MartinInsiderBuy225,000GBX 0.08£180
6/12/2015Martin DiggleInsiderBuy283,978GBX 9.01£25,586.42
6/11/2015Martin DiggleInsiderBuy416,022GBX 9£37,441.98
6/9/2015Daniel SolandInsiderBuy500,000GBX 9.45£47,250
5/21/2015Andrew HeathInsiderBuy100,000GBX 10.60£10,600
5/19/2015Tim WattsInsiderBuy194,174GBX 10.30£19,999.92
(Data available from 1/1/2013 forward)


Headline Trends for Oxford BioMedica plc (LON:OXB)
Latest Headlines for Oxford BioMedica plc (LON:OXB)


Social activity is not available for this stock.


Oxford BioMedica plc (OXB) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff